← Leaderboards
Sharmila Dorbala
Brigham And Women'S Hospital
$7,782,663
Attributed
$14,248,133
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.7M · FY2009–25$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,248,133 · 5
By mechanism
R01$12,930,940 · 3
K23$705,006 · 1
K24$612,187 · 1
Top collaborators
- Rodney H Falk4 shared
- Joao A C Lima4 shared
- Amil M Shah4 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Ronilda Lacson$6,815,907
- Steven Michael Jay$4,441,396
- Amil M Shah$21,763,052
- Farbod Nicholas Rahaghi$4,904,428
- Sarah Am Cuddy$571,911
Others in their field
Top investigators on “Image”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$332,241,999
- Leonard Freedman · Leidos Biomedical Research, Inc.$321,574,964
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$217,904,052
- Ethan Schreier · Associated Universities, Inc.$206,468,864
Research focus
ImageHeart FailureCardiacMyocardiumAmyloidosisHeartPreventWomanMyocardialNovel StrategiesPathway InteractionsLeftVentricularDiphosphatesFoundationsAffectProteinsPrealbuminDepositionMortalityCessation Of LifeDiagnosisExtracellularAmyloid Fibrils
Grant awards (22)
Interplay of Myocardial Fibrosis and Cardiac TTR Amyloid in Age Related Cardiac Remodeling in MESA-Multi-Ethnic Study of Atherosclerosis$1,364,939
R01 · FY2025 · HL
Mentoring Patient Oriented Research in Innovative Imaging and High-dimensional Data Approaches to Improve Outcomes in Cardiac Amyloidosis$123,785
K24 · FY2025 · HL · contact PI
Interplay of Myocardial Fibrosis and Cardiac TTR Amyloid in Age Related Cardiac Remodeling in MESA-Multi-Ethnic Study of Atherosclerosis$1,347,391
R01 · FY2024 · HL
Mentoring Patient Oriented Research in Innovative Imaging and High-dimensional Data Approaches to Improve Outcomes in Cardiac Amyloidosis$123,785
K24 · FY2024 · HL · contact PI
Interplay of Myocardial Fibrosis and Cardiac TTR Amyloid in Age Related Cardiac Remodeling in MESA-Multi-Ethnic Study of Atherosclerosis$1,378,634
R01 · FY2023 · HL
Early Detection of Transthyretin Cardiac Amyloidosis: Defining a Novel Target for HFpEF Treatment and Prevention in Late Life$827,451
R01 · FY2023 · HL · contact PI
Mentoring Patient Oriented Research in Innovative Imaging and High-dimensional Data Approaches to Improve Outcomes in Cardiac Amyloidosis$121,556
K24 · FY2023 · HL · contact PI
Interplay of Myocardial Fibrosis and Cardiac TTR Amyloid in Age Related Cardiac Remodeling in MESA-Multi-Ethnic Study of Atherosclerosis$1,461,844
R01 · FY2022 · HL
Early Detection of Transthyretin Cardiac Amyloidosis: Defining a Novel Target for HFpEF Treatment and Prevention in Late Life$1,102,200
R01 · FY2022 · HL · contact PI
Mentoring Patient Oriented Research in Innovative Imaging and High-dimensional Data Approaches to Improve Outcomes in Cardiac Amyloidosis$121,462
K24 · FY2022 · HL · contact PI
Early Detection of Transthyretin Cardiac Amyloidosis: Defining a Novel Target for HFpEF Treatment and Prevention in Late Life$1,109,964
R01 · FY2021 · HL · contact PI
Mentoring Patient Oriented Research in Innovative Imaging and High-dimensional Data Approaches to Improve Outcomes in Cardiac Amyloidosis$121,599
K24 · FY2021 · HL · contact PI
Early Detection of Transthyretin Cardiac Amyloidosis: Defining a Novel Target for HFpEF Treatment and Prevention in Late Life$1,040,412
R01 · FY2020 · HL · contact PI
Molecular Imaging of Primary Amyloid Cardiomyopathy$801,025
R01 · FY2019 · HL · contact PI
Molecular Imaging of Primary Amyloid Cardiomyopathy$801,025
R01 · FY2018 · HL · contact PI
Molecular Imaging of Primary Amyloid Cardiomyopathy$823,259
R01 · FY2017 · HL · contact PI
Molecular Imaging of Primary Amyloid Cardiomyopathy$872,796
R01 · FY2016 · HL · contact PI
Prognostic Utility of Absolute Coronary Microvascular Function by PET/CT$141,012
K23 · FY2013 · HL · contact PI
Prognostic Utility of Absolute Coronary Microvascular Function by PET/CT$141,012
K23 · FY2012 · HL · contact PI
Prognostic Utility of Absolute Coronary Microvascular Function by PET/CT$140,999
K23 · FY2011 · HL · contact PI
Prognostic Utility of Absolute Coronary Microvascular Function by PET/CT$140,992
K23 · FY2010 · HL · contact PI
Prognostic Utility of Absolute Coronary Microvascular Function by PET/CT$140,991
K23 · FY2009 · HL · contact PI